Alec Stranahan
Stock Analyst at Bank of America Securities
(4.33)
# 1,315
Out of 4,592 analysts
600
Total ratings
49.2%
Success rate
7.8%
Average return
Main Sectors:
Stocks Rated by Alec Stranahan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGIO Agios Pharmaceuticals | Reiterated: Buy | $46 | $32.75 | +40.46% | 34 | Jul 30, 2026 | |
| ERAS Erasca | Reiterated: Hold | $16 → $18 | $18.55 | -2.94% | 26 | Jul 14, 2026 | |
| KRYS Krystal Biotech | Maintained: Buy | $364 → $396 | $366.80 | +7.96% | 31 | Jul 13, 2026 | |
| BEAM Beam Therapeutics | Maintained: Buy | $47 | $26.54 | +77.09% | 23 | Jul 8, 2026 | |
| NVAX Novavax | Maintained: Sell | $8 | $7.41 | +7.96% | 41 | Jul 7, 2026 | |
| TGTX TG Therapeutics | Reiterated: Sell | $17 → $20 | $53.09 | -62.33% | 37 | Jul 7, 2026 | |
| HCM HUTCHMED (China) | Reiterated: Buy | $20 → $17 | $10.88 | +56.25% | 22 | Jul 7, 2026 | |
| CRSP CRISPR Therapeutics AG | Maintained: Buy | $83 | $48.19 | +72.23% | 26 | Jul 7, 2026 | |
| MGTX MeiraGTx Holdings | Maintained: Buy | $16 → $19 | $11.75 | +61.70% | 16 | Jul 7, 2026 | |
| MRNA Moderna | Reiterated: Sell | $34 → $38 | $58.31 | -34.83% | 24 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $212 | $191.10 | +10.94% | 35 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $11.08 | +71.48% | 18 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $35 | $19.70 | +77.66% | 1 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 | $1.52 | +294.74% | 15 | Jun 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $2.94 | +104.08% | 17 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 | $8.98 | +89.31% | 17 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 | $10.00 | -10.00% | 17 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 | $23.00 | +47.83% | 8 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 | $8.81 | +81.61% | 20 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $87 | $72.13 | +20.62% | 18 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $14 | $10.18 | +37.52% | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $21.27 | -20.08% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $3.06 | +96.08% | 22 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.26 | +114.72% | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $21 | $15.55 | +35.05% | 21 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.67 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.62 | - | 15 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $19 | $5.70 | +233.33% | 5 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1 | $0.81 | +23.46% | 13 | Mar 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $800 → $565 | $729.29 | n/a | 3 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $1,150 → $1,100 | $1,145.04 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $5 | $29.21 | n/a | 2 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $1 | $5.05 | n/a | 4 | Dec 2, 2022 |
Agios Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $46
Current: $32.75
Upside: +40.46%
Erasca
Jul 14, 2026
Reiterated: Hold
Price Target: $16 → $18
Current: $18.55
Upside: -2.94%
Krystal Biotech
Jul 13, 2026
Maintained: Buy
Price Target: $364 → $396
Current: $366.80
Upside: +7.96%
Beam Therapeutics
Jul 8, 2026
Maintained: Buy
Price Target: $47
Current: $26.54
Upside: +77.09%
Novavax
Jul 7, 2026
Maintained: Sell
Price Target: $8
Current: $7.41
Upside: +7.96%
TG Therapeutics
Jul 7, 2026
Reiterated: Sell
Price Target: $17 → $20
Current: $53.09
Upside: -62.33%
HUTCHMED (China)
Jul 7, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $10.88
Upside: +56.25%
CRISPR Therapeutics AG
Jul 7, 2026
Maintained: Buy
Price Target: $83
Current: $48.19
Upside: +72.23%
MeiraGTx Holdings
Jul 7, 2026
Maintained: Buy
Price Target: $16 → $19
Current: $11.75
Upside: +61.70%
Moderna
Jul 7, 2026
Reiterated: Sell
Price Target: $34 → $38
Current: $58.31
Upside: -34.83%
Jun 25, 2026
Reiterated: Buy
Price Target: $185 → $212
Current: $191.10
Upside: +10.94%
Jun 15, 2026
Maintained: Hold
Price Target: $19
Current: $11.08
Upside: +71.48%
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $19.70
Upside: +77.66%
Jun 11, 2026
Maintained: Buy
Price Target: $6
Current: $1.52
Upside: +294.74%
May 31, 2026
Maintained: Hold
Price Target: $6
Current: $2.94
Upside: +104.08%
May 31, 2026
Maintained: Buy
Price Target: $17
Current: $8.98
Upside: +89.31%
May 31, 2026
Maintained: Hold
Price Target: $9
Current: $10.00
Upside: -10.00%
May 31, 2026
Maintained: Buy
Price Target: $34
Current: $23.00
Upside: +47.83%
May 29, 2026
Maintained: Buy
Price Target: $16
Current: $8.81
Upside: +81.61%
May 26, 2026
Maintained: Buy
Price Target: $83 → $87
Current: $72.13
Upside: +20.62%
May 14, 2026
Reiterated: Buy
Price Target: $25 → $14
Current: $10.18
Upside: +37.52%
May 13, 2026
Maintained: Hold
Price Target: $17
Current: $21.27
Upside: -20.08%
May 13, 2026
Maintained: Hold
Price Target: $6
Current: $3.06
Upside: +96.08%
May 12, 2026
Reiterated: Buy
Price Target: $7
Current: $3.26
Upside: +114.72%
May 8, 2026
Reiterated: Buy
Price Target: $24 → $21
Current: $15.55
Upside: +35.05%
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $2.67
Upside: -
Apr 30, 2026
Maintained: Sell
Price Target: n/a
Current: $1.62
Upside: -
Apr 28, 2026
Maintained: Buy
Price Target: $21 → $19
Current: $5.70
Upside: +233.33%
Mar 27, 2026
Reiterated: Sell
Price Target: $1
Current: $0.81
Upside: +23.46%
Dec 10, 2024
Initiated Coverage: Sell
Price Target: $800 → $565
Current: $729.29
Upside: n/a
Nov 1, 2024
Rated: Buy
Price Target: $1,150 → $1,100
Current: $1,145.04
Upside: n/a
Aug 15, 2023
Reiterated: Buy
Price Target: $6 → $5
Current: $29.21
Upside: n/a
Dec 2, 2022
Maintained: Sell
Price Target: $10 → $1
Current: $5.05
Upside: n/a